Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies’ research progress. Here’s a list of conferences to watch for in 2027.
The purchase expands GE HealthCare’s radiopharmaceutical capabilities, helping manufacture and distribute time-sensitive ...
The acquisition of Texas-based IntraBio adds to a growing rare disease business for Shionogi by handing the company a ...
The Nobel laureates “laid the foundation” for a new field of brain research, the award committee wrote. Elsewhere, Roche and ...
The company’s next-generation shot surpassed Wall Street’s expectations by matching the effectiveness of vaccines from Pfizer ...
The latest installment in BioPharma Dive’s data visualization series features a closer look at Kodiak’s stock performance and ...
In exchange for a $575 million payment up front, Abogen Biosciences will furnish Novartis with access to its RNA technology, including an option to license its lead program ABO-2203.
Zepbound combination data. Elsewhere, Novo demonstrated continued weight loss following a switch to oral and AbbVie and ...
The pharma giant cut its partnership after a cancer drug disappointed in testing. Elsewhere, Teva and Samsung Bioepis expanded a partnership and space biotech Varda brought in $251 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results